Cargando…

A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients

RapidPlan, a commercial knowledge‐based optimizer, has been tested on head and neck, lung, esophageal, breast, liver, and prostate cancer patients. To appraise its performance on VMAT planning with simultaneous integrated boosting (SIB) for rectal cancer, this study configured a DVH (dose‐volume his...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao, Jiang, Fan, Yue, Haizhen, Li, Sha, Zhang, Yibao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690500/
https://www.ncbi.nlm.nih.gov/pubmed/27929483
http://dx.doi.org/10.1120/jacmp.v17i6.6410
_version_ 1783279620777312256
author Wu, Hao
Jiang, Fan
Yue, Haizhen
Li, Sha
Zhang, Yibao
author_facet Wu, Hao
Jiang, Fan
Yue, Haizhen
Li, Sha
Zhang, Yibao
author_sort Wu, Hao
collection PubMed
description RapidPlan, a commercial knowledge‐based optimizer, has been tested on head and neck, lung, esophageal, breast, liver, and prostate cancer patients. To appraise its performance on VMAT planning with simultaneous integrated boosting (SIB) for rectal cancer, this study configured a DVH (dose‐volume histogram) estimation model consisting 80 best‐effort manual cases of this type. Using the model‐ generated objectives, the MLC (multileaf collimator) sequences of other 70 clinically approved plans were reoptimized, while the remaining parameters, such as field geometry and photon energy, were maintained. Dosimetric outcomes were assessed by comparing homogeneity index (HI), conformal index (CI), hot spots (volumes receiving over 107% of the prescribed dose, [Formula: see text]), mean dose and dose to the 50% volume of femoral head ([Formula: see text] and [Formula: see text]), and urinary bladder ([Formula: see text] and [Formula: see text]), and the mean DVH plotting. Paired samples t‐test or Wilcoxon signed‐rank test suggested that comparable CI were achieved by RapidPlan ([Formula: see text] for [Formula: see text] , and [Formula: see text] for PTV) and original plans ([Formula: see text] for [Formula: see text] and [Formula: see text] for PTV), respectively [Formula: see text]. Slightly improved HI of planning target volume [Formula: see text] and PTV were observed in the RapidPlan cases ([Formula: see text] for [Formula: see text] , and [Formula: see text] for PTV) than the original plans ([Formula: see text] for [Formula: see text] and [Formula: see text] for PTV), [Formula: see text]. More cases with positive [Formula: see text] were found in the original (18 plans) than the RapidPlan group (none). RapidPlan significantly reduced the [Formula: see text] (by [Formula: see text] from [Formula: see text] to [Formula: see text]), [Formula: see text] (by [Formula: see text] from [Formula: see text] to [Formula: see text] G), [Formula: see text] (by [Formula: see text] from [Formula: see text] to [Formula: see text]), and [Formula: see text] (by [Formula: see text] from [Formula: see text] to [Formula: see text]), respectively. The more concentrated distribution of RapidPlan data points indicated an enhanced consistency of plan quality. PACS number(s): 87.55.de; 87.55.dk
format Online
Article
Text
id pubmed-5690500
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56905002018-04-02 A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients Wu, Hao Jiang, Fan Yue, Haizhen Li, Sha Zhang, Yibao J Appl Clin Med Phys Radiation Oncology Physics RapidPlan, a commercial knowledge‐based optimizer, has been tested on head and neck, lung, esophageal, breast, liver, and prostate cancer patients. To appraise its performance on VMAT planning with simultaneous integrated boosting (SIB) for rectal cancer, this study configured a DVH (dose‐volume histogram) estimation model consisting 80 best‐effort manual cases of this type. Using the model‐ generated objectives, the MLC (multileaf collimator) sequences of other 70 clinically approved plans were reoptimized, while the remaining parameters, such as field geometry and photon energy, were maintained. Dosimetric outcomes were assessed by comparing homogeneity index (HI), conformal index (CI), hot spots (volumes receiving over 107% of the prescribed dose, [Formula: see text]), mean dose and dose to the 50% volume of femoral head ([Formula: see text] and [Formula: see text]), and urinary bladder ([Formula: see text] and [Formula: see text]), and the mean DVH plotting. Paired samples t‐test or Wilcoxon signed‐rank test suggested that comparable CI were achieved by RapidPlan ([Formula: see text] for [Formula: see text] , and [Formula: see text] for PTV) and original plans ([Formula: see text] for [Formula: see text] and [Formula: see text] for PTV), respectively [Formula: see text]. Slightly improved HI of planning target volume [Formula: see text] and PTV were observed in the RapidPlan cases ([Formula: see text] for [Formula: see text] , and [Formula: see text] for PTV) than the original plans ([Formula: see text] for [Formula: see text] and [Formula: see text] for PTV), [Formula: see text]. More cases with positive [Formula: see text] were found in the original (18 plans) than the RapidPlan group (none). RapidPlan significantly reduced the [Formula: see text] (by [Formula: see text] from [Formula: see text] to [Formula: see text]), [Formula: see text] (by [Formula: see text] from [Formula: see text] to [Formula: see text] G), [Formula: see text] (by [Formula: see text] from [Formula: see text] to [Formula: see text]), and [Formula: see text] (by [Formula: see text] from [Formula: see text] to [Formula: see text]), respectively. The more concentrated distribution of RapidPlan data points indicated an enhanced consistency of plan quality. PACS number(s): 87.55.de; 87.55.dk John Wiley and Sons Inc. 2016-11-08 /pmc/articles/PMC5690500/ /pubmed/27929483 http://dx.doi.org/10.1120/jacmp.v17i6.6410 Text en © 2016 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Wu, Hao
Jiang, Fan
Yue, Haizhen
Li, Sha
Zhang, Yibao
A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients
title A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients
title_full A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients
title_fullStr A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients
title_full_unstemmed A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients
title_short A dosimetric evaluation of knowledge‐based VMAT planning with simultaneous integrated boosting for rectal cancer patients
title_sort dosimetric evaluation of knowledge‐based vmat planning with simultaneous integrated boosting for rectal cancer patients
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690500/
https://www.ncbi.nlm.nih.gov/pubmed/27929483
http://dx.doi.org/10.1120/jacmp.v17i6.6410
work_keys_str_mv AT wuhao adosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT jiangfan adosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT yuehaizhen adosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT lisha adosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT zhangyibao adosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT wuhao dosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT jiangfan dosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT yuehaizhen dosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT lisha dosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients
AT zhangyibao dosimetricevaluationofknowledgebasedvmatplanningwithsimultaneousintegratedboostingforrectalcancerpatients